id	sid	tid	token	lemma	pos
work_4qabwxy7effildblswnw7mkrvi	1	1	Dollco	Dollco	NNP
work_4qabwxy7effildblswnw7mkrvi	1	2	S	S	NNP
work_4qabwxy7effildblswnw7mkrvi	1	3	implify	implify	NNP
work_4qabwxy7effildblswnw7mkrvi	1	4	,	,	,
work_4qabwxy7effildblswnw7mkrvi	1	5	simplify	simplify	VB
work_4qabwxy7effildblswnw7mkrvi	1	6	,	,	,
work_4qabwxy7effildblswnw7mkrvi	1	7	simplify	simplify	NNP
work_4qabwxy7effildblswnw7mkrvi	1	8	!	!	.
work_4qabwxy7effildblswnw7mkrvi	2	1	So	so	RB
work_4qabwxy7effildblswnw7mkrvi	2	2	instructed	instruct	VBD
work_4qabwxy7effildblswnw7mkrvi	2	3	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	2	4	philosopher	philosopher	NN
work_4qabwxy7effildblswnw7mkrvi	2	5	Henry	Henry	NNP
work_4qabwxy7effildblswnw7mkrvi	2	6	David	David	NNP
work_4qabwxy7effildblswnw7mkrvi	2	7	Thoreau	Thoreau	NNP
work_4qabwxy7effildblswnw7mkrvi	2	8	,	,	,
work_4qabwxy7effildblswnw7mkrvi	2	9	who	who	WP
work_4qabwxy7effildblswnw7mkrvi	2	10	believed	believe	VBD
work_4qabwxy7effildblswnw7mkrvi	2	11	a	a	DT
work_4qabwxy7effildblswnw7mkrvi	2	12	life	life	NN
work_4qabwxy7effildblswnw7mkrvi	2	13	lived	live	VBD
work_4qabwxy7effildblswnw7mkrvi	2	14	simply	simply	RB
work_4qabwxy7effildblswnw7mkrvi	2	15	was	be	VBD
work_4qabwxy7effildblswnw7mkrvi	2	16	a	a	DT
work_4qabwxy7effildblswnw7mkrvi	2	17	life	life	NN
work_4qabwxy7effildblswnw7mkrvi	2	18	better	well	RBR
work_4qabwxy7effildblswnw7mkrvi	2	19	lived	live	VBD
work_4qabwxy7effildblswnw7mkrvi	2	20	,	,	,
work_4qabwxy7effildblswnw7mkrvi	2	21	in	in	IN
work_4qabwxy7effildblswnw7mkrvi	2	22	his	-PRON-	PRP$
work_4qabwxy7effildblswnw7mkrvi	2	23	157-year	157-year	CD
work_4qabwxy7effildblswnw7mkrvi	2	24	-	-	HYPH
work_4qabwxy7effildblswnw7mkrvi	2	25	old	old	JJ
work_4qabwxy7effildblswnw7mkrvi	2	26	classic	classic	JJ
work_4qabwxy7effildblswnw7mkrvi	2	27	book	book	NN
work_4qabwxy7effildblswnw7mkrvi	2	28	Walden	Walden	NNP
work_4qabwxy7effildblswnw7mkrvi	2	29	.	.	.
work_4qabwxy7effildblswnw7mkrvi	3	1	These	these	DT
work_4qabwxy7effildblswnw7mkrvi	3	2	words	word	NNS
work_4qabwxy7effildblswnw7mkrvi	3	3	also	also	RB
work_4qabwxy7effildblswnw7mkrvi	3	4	seem	seem	VBP
work_4qabwxy7effildblswnw7mkrvi	3	5	apropos	apropos	NN
work_4qabwxy7effildblswnw7mkrvi	3	6	in	in	IN
work_4qabwxy7effildblswnw7mkrvi	3	7	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	3	8	increasingly	increasingly	RB
work_4qabwxy7effildblswnw7mkrvi	3	9	complex	complex	JJ
work_4qabwxy7effildblswnw7mkrvi	3	10	world	world	NN
work_4qabwxy7effildblswnw7mkrvi	3	11	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	3	12	health	health	NN
work_4qabwxy7effildblswnw7mkrvi	3	13	care	care	NN
work_4qabwxy7effildblswnw7mkrvi	3	14	,	,	,
work_4qabwxy7effildblswnw7mkrvi	3	15	where	where	WRB
work_4qabwxy7effildblswnw7mkrvi	3	16	making	make	VBG
work_4qabwxy7effildblswnw7mkrvi	3	17	care	care	NN
work_4qabwxy7effildblswnw7mkrvi	3	18	simpler	simple	JJR
work_4qabwxy7effildblswnw7mkrvi	3	19	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	3	20	patients	patient	NNS
work_4qabwxy7effildblswnw7mkrvi	3	21	has	have	VBZ
work_4qabwxy7effildblswnw7mkrvi	3	22	been	be	VBN
work_4qabwxy7effildblswnw7mkrvi	3	23	shown	show	VBN
work_4qabwxy7effildblswnw7mkrvi	3	24	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	3	25	reap	reap	VB
work_4qabwxy7effildblswnw7mkrvi	3	26	benefits	benefit	NNS
work_4qabwxy7effildblswnw7mkrvi	3	27	.	.	.
work_4qabwxy7effildblswnw7mkrvi	4	1	“	"	``
work_4qabwxy7effildblswnw7mkrvi	4	2	One	one	CD
work_4qabwxy7effildblswnw7mkrvi	4	3	way	way	NN
work_4qabwxy7effildblswnw7mkrvi	4	4	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	4	5	get	get	VB
work_4qabwxy7effildblswnw7mkrvi	4	6	around	around	IN
work_4qabwxy7effildblswnw7mkrvi	4	7	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	4	8	com-	com-	NN
work_4qabwxy7effildblswnw7mkrvi	4	9	plexity	plexity	NN
work_4qabwxy7effildblswnw7mkrvi	4	10	issue	issue	NN
work_4qabwxy7effildblswnw7mkrvi	4	11	is	be	VBZ
work_4qabwxy7effildblswnw7mkrvi	4	12	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	4	13	make	make	VB
work_4qabwxy7effildblswnw7mkrvi	4	14	a	a	DT
work_4qabwxy7effildblswnw7mkrvi	4	15	drug	drug	NN
work_4qabwxy7effildblswnw7mkrvi	4	16	regimen	regimen	NN
work_4qabwxy7effildblswnw7mkrvi	4	17	less	less	RBR
work_4qabwxy7effildblswnw7mkrvi	4	18	complicated	complicated	JJ
work_4qabwxy7effildblswnw7mkrvi	4	19	,	,	,
work_4qabwxy7effildblswnw7mkrvi	4	20	”	"	''
work_4qabwxy7effildblswnw7mkrvi	4	21	says	say	VBZ
work_4qabwxy7effildblswnw7mkrvi	4	22	Dr.	Dr.	NNP
work_4qabwxy7effildblswnw7mkrvi	4	23	Mark	Mark	NNP
work_4qabwxy7effildblswnw7mkrvi	4	24	Fendrick	Fendrick	NNP
work_4qabwxy7effildblswnw7mkrvi	4	25	,	,	,
work_4qabwxy7effildblswnw7mkrvi	4	26	professor	professor	NN
work_4qabwxy7effildblswnw7mkrvi	4	27	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	4	28	health	health	NNP
work_4qabwxy7effildblswnw7mkrvi	4	29	manage-	manage-	NNP
work_4qabwxy7effildblswnw7mkrvi	4	30	ment	ment	NN
work_4qabwxy7effildblswnw7mkrvi	4	31	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	4	32	policy	policy	NN
work_4qabwxy7effildblswnw7mkrvi	4	33	at	at	IN
work_4qabwxy7effildblswnw7mkrvi	4	34	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	4	35	University	University	NNP
work_4qabwxy7effildblswnw7mkrvi	4	36	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	4	37	Michigan	Michigan	NNP
work_4qabwxy7effildblswnw7mkrvi	4	38	in	in	IN
work_4qabwxy7effildblswnw7mkrvi	4	39	Ann	Ann	NNP
work_4qabwxy7effildblswnw7mkrvi	4	40	Arbor	Arbor	NNP
work_4qabwxy7effildblswnw7mkrvi	4	41	.	.	.
work_4qabwxy7effildblswnw7mkrvi	5	1	“	"	``
work_4qabwxy7effildblswnw7mkrvi	5	2	How	how	WRB
work_4qabwxy7effildblswnw7mkrvi	5	3	do	do	VBP
work_4qabwxy7effildblswnw7mkrvi	5	4	you	-PRON-	PRP
work_4qabwxy7effildblswnw7mkrvi	5	5	do	do	VB
work_4qabwxy7effildblswnw7mkrvi	5	6	that	that	DT
work_4qabwxy7effildblswnw7mkrvi	5	7	?	?	.
work_4qabwxy7effildblswnw7mkrvi	6	1	You	-PRON-	PRP
work_4qabwxy7effildblswnw7mkrvi	6	2	take	take	VBP
work_4qabwxy7effildblswnw7mkrvi	6	3	two	two	CD
work_4qabwxy7effildblswnw7mkrvi	6	4	pills	pill	NNS
work_4qabwxy7effildblswnw7mkrvi	6	5	you	-PRON-	PRP
work_4qabwxy7effildblswnw7mkrvi	6	6	take	take	VBP
work_4qabwxy7effildblswnw7mkrvi	6	7	every	every	DT
work_4qabwxy7effildblswnw7mkrvi	6	8	day	day	NN
work_4qabwxy7effildblswnw7mkrvi	6	9	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	6	10	make	make	VB
work_4qabwxy7effildblswnw7mkrvi	6	11	them	-PRON-	PRP
work_4qabwxy7effildblswnw7mkrvi	6	12	into	into	IN
work_4qabwxy7effildblswnw7mkrvi	6	13	one	one	CD
work_4qabwxy7effildblswnw7mkrvi	6	14	.	.	.
work_4qabwxy7effildblswnw7mkrvi	6	15	”	"	''
work_4qabwxy7effildblswnw7mkrvi	6	16	As	as	IN
work_4qabwxy7effildblswnw7mkrvi	6	17	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	6	18	burden	burden	NN
work_4qabwxy7effildblswnw7mkrvi	6	19	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	6	20	chronic	chronic	JJ
work_4qabwxy7effildblswnw7mkrvi	6	21	diseases	disease	NNS
work_4qabwxy7effildblswnw7mkrvi	6	22	,	,	,
work_4qabwxy7effildblswnw7mkrvi	6	23	which	which	WDT
work_4qabwxy7effildblswnw7mkrvi	6	24	often	often	RB
work_4qabwxy7effildblswnw7mkrvi	6	25	require	require	VBP
work_4qabwxy7effildblswnw7mkrvi	6	26	multiple	multiple	JJ
work_4qabwxy7effildblswnw7mkrvi	6	27	medica-	medica-	JJ
work_4qabwxy7effildblswnw7mkrvi	6	28	tions	tion	NNS
work_4qabwxy7effildblswnw7mkrvi	6	29	,	,	,
work_4qabwxy7effildblswnw7mkrvi	6	30	increases	increase	NNS
work_4qabwxy7effildblswnw7mkrvi	6	31	around	around	IN
work_4qabwxy7effildblswnw7mkrvi	6	32	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	6	33	world	world	NN
work_4qabwxy7effildblswnw7mkrvi	6	34	,	,	,
work_4qabwxy7effildblswnw7mkrvi	6	35	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	6	36	appeal	appeal	NN
work_4qabwxy7effildblswnw7mkrvi	6	37	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	6	38	fixed	fix	VBN
work_4qabwxy7effildblswnw7mkrvi	6	39	-	-	HYPH
work_4qabwxy7effildblswnw7mkrvi	6	40	dose	dose	NN
work_4qabwxy7effildblswnw7mkrvi	6	41	combination	combination	NN
work_4qabwxy7effildblswnw7mkrvi	6	42	drugs	drug	NNS
work_4qabwxy7effildblswnw7mkrvi	6	43	may	may	MD
work_4qabwxy7effildblswnw7mkrvi	6	44	also	also	RB
work_4qabwxy7effildblswnw7mkrvi	6	45	increase	increase	VB
work_4qabwxy7effildblswnw7mkrvi	6	46	.	.	.
work_4qabwxy7effildblswnw7mkrvi	7	1	These	these	DT
work_4qabwxy7effildblswnw7mkrvi	7	2	products	product	NNS
work_4qabwxy7effildblswnw7mkrvi	7	3	,	,	,
work_4qabwxy7effildblswnw7mkrvi	7	4	which	which	WDT
work_4qabwxy7effildblswnw7mkrvi	7	5	combine	combine	VBP
work_4qabwxy7effildblswnw7mkrvi	7	6	two	two	CD
work_4qabwxy7effildblswnw7mkrvi	7	7	or	or	CC
work_4qabwxy7effildblswnw7mkrvi	7	8	more	more	JJR
work_4qabwxy7effildblswnw7mkrvi	7	9	drugs	drug	NNS
work_4qabwxy7effildblswnw7mkrvi	7	10	into	into	IN
work_4qabwxy7effildblswnw7mkrvi	7	11	a	a	DT
work_4qabwxy7effildblswnw7mkrvi	7	12	single	single	JJ
work_4qabwxy7effildblswnw7mkrvi	7	13	tablet	tablet	NN
work_4qabwxy7effildblswnw7mkrvi	7	14	,	,	,
work_4qabwxy7effildblswnw7mkrvi	7	15	have	have	VBP
work_4qabwxy7effildblswnw7mkrvi	7	16	been	be	VBN
work_4qabwxy7effildblswnw7mkrvi	7	17	shown	show	VBN
work_4qabwxy7effildblswnw7mkrvi	7	18	time	time	NN
work_4qabwxy7effildblswnw7mkrvi	7	19	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	7	20	again	again	RB
work_4qabwxy7effildblswnw7mkrvi	7	21	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	7	22	increase	increase	VB
work_4qabwxy7effildblswnw7mkrvi	7	23	adherence	adherence	NN
work_4qabwxy7effildblswnw7mkrvi	7	24	to	to	IN
work_4qabwxy7effildblswnw7mkrvi	7	25	drug	drug	NN
work_4qabwxy7effildblswnw7mkrvi	7	26	regimens	regimen	NNS
work_4qabwxy7effildblswnw7mkrvi	7	27	.	.	.
work_4qabwxy7effildblswnw7mkrvi	8	1	In	in	IN
work_4qabwxy7effildblswnw7mkrvi	8	2	one	one	CD
work_4qabwxy7effildblswnw7mkrvi	8	3	study	study	NN
work_4qabwxy7effildblswnw7mkrvi	8	4	,	,	,
work_4qabwxy7effildblswnw7mkrvi	8	5	to	to	IN
work_4qabwxy7effildblswnw7mkrvi	8	6	which	which	WDT
work_4qabwxy7effildblswnw7mkrvi	8	7	Fendrick	Fendrick	NNP
work_4qabwxy7effildblswnw7mkrvi	8	8	con-	con-	NN
work_4qabwxy7effildblswnw7mkrvi	8	9	tributed	tribute	VBD
work_4qabwxy7effildblswnw7mkrvi	8	10	,	,	,
work_4qabwxy7effildblswnw7mkrvi	8	11	9170	9170	CD
work_4qabwxy7effildblswnw7mkrvi	8	12	people	people	NNS
work_4qabwxy7effildblswnw7mkrvi	8	13	with	with	IN
work_4qabwxy7effildblswnw7mkrvi	8	14	diabetes	diabete	NNS
work_4qabwxy7effildblswnw7mkrvi	8	15	were	be	VBD
work_4qabwxy7effildblswnw7mkrvi	8	16	treated	treat	VBN
work_4qabwxy7effildblswnw7mkrvi	8	17	either	either	CC
work_4qabwxy7effildblswnw7mkrvi	8	18	with	with	IN
work_4qabwxy7effildblswnw7mkrvi	8	19	two	two	CD
work_4qabwxy7effildblswnw7mkrvi	8	20	medica-	medica-	JJ
work_4qabwxy7effildblswnw7mkrvi	8	21	tions	tion	NNS
work_4qabwxy7effildblswnw7mkrvi	8	22	or	or	CC
work_4qabwxy7effildblswnw7mkrvi	8	23	with	with	IN
work_4qabwxy7effildblswnw7mkrvi	8	24	a	a	DT
work_4qabwxy7effildblswnw7mkrvi	8	25	fixed	fix	VBN
work_4qabwxy7effildblswnw7mkrvi	8	26	-	-	HYPH
work_4qabwxy7effildblswnw7mkrvi	8	27	dose	dose	NN
work_4qabwxy7effildblswnw7mkrvi	8	28	combination	combination	NN
work_4qabwxy7effildblswnw7mkrvi	8	29	product	product	NN
work_4qabwxy7effildblswnw7mkrvi	8	30	(	(	-LRB-
work_4qabwxy7effildblswnw7mkrvi	8	31	J	J	NNP
work_4qabwxy7effildblswnw7mkrvi	8	32	Gen	Gen	NNP
work_4qabwxy7effildblswnw7mkrvi	8	33	Intern	Intern	NNP
work_4qabwxy7effildblswnw7mkrvi	8	34	Med	Med	NNP
work_4qabwxy7effildblswnw7mkrvi	8	35	2008	2008	CD
work_4qabwxy7effildblswnw7mkrvi	8	36	;	;	:
work_4qabwxy7effildblswnw7mkrvi	8	37	23:611	23:611	CD
work_4qabwxy7effildblswnw7mkrvi	8	38	-	-	SYM
work_4qabwxy7effildblswnw7mkrvi	8	39	4	4	CD
work_4qabwxy7effildblswnw7mkrvi	8	40	)	)	-RRB-
work_4qabwxy7effildblswnw7mkrvi	8	41	.	.	.
work_4qabwxy7effildblswnw7mkrvi	9	1	Adherence	adherence	NN
work_4qabwxy7effildblswnw7mkrvi	9	2	to	to	IN
work_4qabwxy7effildblswnw7mkrvi	9	3	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	9	4	drug	drug	NN
work_4qabwxy7effildblswnw7mkrvi	9	5	regi-	regi-	NN
work_4qabwxy7effildblswnw7mkrvi	9	6	men	man	NNS
work_4qabwxy7effildblswnw7mkrvi	9	7	was	be	VBD
work_4qabwxy7effildblswnw7mkrvi	9	8	12.8	12.8	CD
work_4qabwxy7effildblswnw7mkrvi	9	9	%	%	NN
work_4qabwxy7effildblswnw7mkrvi	9	10	higher	high	JJR
work_4qabwxy7effildblswnw7mkrvi	9	11	in	in	IN
work_4qabwxy7effildblswnw7mkrvi	9	12	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	9	13	group	group	NN
work_4qabwxy7effildblswnw7mkrvi	9	14	that	that	WDT
work_4qabwxy7effildblswnw7mkrvi	9	15	took	take	VBD
work_4qabwxy7effildblswnw7mkrvi	9	16	a	a	DT
work_4qabwxy7effildblswnw7mkrvi	9	17	single	single	JJ
work_4qabwxy7effildblswnw7mkrvi	9	18	-	-	HYPH
work_4qabwxy7effildblswnw7mkrvi	9	19	component	component	NN
work_4qabwxy7effildblswnw7mkrvi	9	20	pill	pill	NN
work_4qabwxy7effildblswnw7mkrvi	9	21	.	.	.
work_4qabwxy7effildblswnw7mkrvi	10	1	A	a	DT
work_4qabwxy7effildblswnw7mkrvi	10	2	meta	meta	JJ
work_4qabwxy7effildblswnw7mkrvi	10	3	-	-	HYPH
work_4qabwxy7effildblswnw7mkrvi	10	4	analysis	analysis	NN
work_4qabwxy7effildblswnw7mkrvi	10	5	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	10	6	research	research	NN
work_4qabwxy7effildblswnw7mkrvi	10	7	in	in	IN
work_4qabwxy7effildblswnw7mkrvi	10	8	this	this	DT
work_4qabwxy7effildblswnw7mkrvi	10	9	area	area	NN
work_4qabwxy7effildblswnw7mkrvi	10	10	found	find	VBD
work_4qabwxy7effildblswnw7mkrvi	10	11	an	an	DT
work_4qabwxy7effildblswnw7mkrvi	10	12	even	even	RB
work_4qabwxy7effildblswnw7mkrvi	10	13	greater	great	JJR
work_4qabwxy7effildblswnw7mkrvi	10	14	positive	positive	JJ
work_4qabwxy7effildblswnw7mkrvi	10	15	effect	effect	NN
work_4qabwxy7effildblswnw7mkrvi	10	16	(	(	-LRB-
work_4qabwxy7effildblswnw7mkrvi	10	17	Am	Am	NNP
work_4qabwxy7effildblswnw7mkrvi	10	18	J	J	NNP
work_4qabwxy7effildblswnw7mkrvi	10	19	Med	Med	NNP
work_4qabwxy7effildblswnw7mkrvi	10	20	2007;120:713	2007;120:713	CD
work_4qabwxy7effildblswnw7mkrvi	10	21	-	-	SYM
work_4qabwxy7effildblswnw7mkrvi	10	22	9	9	CD
work_4qabwxy7effildblswnw7mkrvi	10	23	)	)	-RRB-
work_4qabwxy7effildblswnw7mkrvi	10	24	.	.	.
work_4qabwxy7effildblswnw7mkrvi	11	1	Noncompliance	noncompliance	NN
work_4qabwxy7effildblswnw7mkrvi	11	2	to	to	IN
work_4qabwxy7effildblswnw7mkrvi	11	3	medication	medication	NN
work_4qabwxy7effildblswnw7mkrvi	11	4	decreased	decrease	VBD
work_4qabwxy7effildblswnw7mkrvi	11	5	by	by	IN
work_4qabwxy7effildblswnw7mkrvi	11	6	26	26	CD
work_4qabwxy7effildblswnw7mkrvi	11	7	%	%	NN
work_4qabwxy7effildblswnw7mkrvi	11	8	when	when	WRB
work_4qabwxy7effildblswnw7mkrvi	11	9	people	people	NNS
work_4qabwxy7effildblswnw7mkrvi	11	10	took	take	VBD
work_4qabwxy7effildblswnw7mkrvi	11	11	fixed	fix	VBN
work_4qabwxy7effildblswnw7mkrvi	11	12	-	-	HYPH
work_4qabwxy7effildblswnw7mkrvi	11	13	dose	dose	VBN
work_4qabwxy7effildblswnw7mkrvi	11	14	combinations	combination	NNS
work_4qabwxy7effildblswnw7mkrvi	11	15	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	11	16	conditions	condition	NNS
work_4qabwxy7effildblswnw7mkrvi	11	17	such	such	JJ
work_4qabwxy7effildblswnw7mkrvi	11	18	as	as	IN
work_4qabwxy7effildblswnw7mkrvi	11	19	hypertension	hypertension	NN
work_4qabwxy7effildblswnw7mkrvi	11	20	,	,	,
work_4qabwxy7effildblswnw7mkrvi	11	21	HIV	HIV	NNP
work_4qabwxy7effildblswnw7mkrvi	11	22	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	11	23	tuberculosis	tuberculosis	NN
work_4qabwxy7effildblswnw7mkrvi	11	24	,	,	,
work_4qabwxy7effildblswnw7mkrvi	11	25	states	state	VBZ
work_4qabwxy7effildblswnw7mkrvi	11	26	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	11	27	paper	paper	NN
work_4qabwxy7effildblswnw7mkrvi	11	28	,	,	,
work_4qabwxy7effildblswnw7mkrvi	11	29	which	which	WDT
work_4qabwxy7effildblswnw7mkrvi	11	30	concludes	conclude	VBZ
work_4qabwxy7effildblswnw7mkrvi	11	31	with	with	IN
work_4qabwxy7effildblswnw7mkrvi	11	32	a	a	DT
work_4qabwxy7effildblswnw7mkrvi	11	33	recommendation	recommendation	NN
work_4qabwxy7effildblswnw7mkrvi	11	34	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	11	35	increased	increase	VBN
work_4qabwxy7effildblswnw7mkrvi	11	36	use	use	NN
work_4qabwxy7effildblswnw7mkrvi	11	37	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	11	38	combination	combination	NN
work_4qabwxy7effildblswnw7mkrvi	11	39	drugs	drug	NNS
work_4qabwxy7effildblswnw7mkrvi	11	40	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	11	41	chronic	chronic	JJ
work_4qabwxy7effildblswnw7mkrvi	11	42	illnesses	illness	NNS
work_4qabwxy7effildblswnw7mkrvi	11	43	.	.	.
work_4qabwxy7effildblswnw7mkrvi	12	1	“	"	``
work_4qabwxy7effildblswnw7mkrvi	12	2	The	the	DT
work_4qabwxy7effildblswnw7mkrvi	12	3	pill	pill	NN
work_4qabwxy7effildblswnw7mkrvi	12	4	burden	burden	NN
work_4qabwxy7effildblswnw7mkrvi	12	5	becomes	become	VBZ
work_4qabwxy7effildblswnw7mkrvi	12	6	an	an	DT
work_4qabwxy7effildblswnw7mkrvi	12	7	issue	issue	NN
work_4qabwxy7effildblswnw7mkrvi	12	8	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	12	9	a	a	DT
work_4qabwxy7effildblswnw7mkrvi	12	10	patient	patient	NN
work_4qabwxy7effildblswnw7mkrvi	12	11	,	,	,
work_4qabwxy7effildblswnw7mkrvi	12	12	”	"	''
work_4qabwxy7effildblswnw7mkrvi	12	13	says	say	VBZ
work_4qabwxy7effildblswnw7mkrvi	12	14	Dr.	Dr.	NNP
work_4qabwxy7effildblswnw7mkrvi	12	15	Franz	Franz	NNP
work_4qabwxy7effildblswnw7mkrvi	12	16	Messerli	Messerli	NNP
work_4qabwxy7effildblswnw7mkrvi	12	17	,	,	,
work_4qabwxy7effildblswnw7mkrvi	12	18	one	one	CD
work_4qabwxy7effildblswnw7mkrvi	12	19	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	12	20	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	12	21	paper	paper	NN
work_4qabwxy7effildblswnw7mkrvi	12	22	’s	’s	POS
work_4qabwxy7effildblswnw7mkrvi	12	23	authors	author	NNS
work_4qabwxy7effildblswnw7mkrvi	12	24	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	12	25	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	12	26	director	director	NN
work_4qabwxy7effildblswnw7mkrvi	12	27	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	12	28	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	12	29	hypertension	hypertension	NN
work_4qabwxy7effildblswnw7mkrvi	12	30	program	program	NN
work_4qabwxy7effildblswnw7mkrvi	12	31	at	at	IN
work_4qabwxy7effildblswnw7mkrvi	12	32	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	12	33	St.	St.	NNP
work_4qabwxy7effildblswnw7mkrvi	12	34	Luke’s	Luke’s	NNP
work_4qabwxy7effildblswnw7mkrvi	12	35	–	–	:
work_4qabwxy7effildblswnw7mkrvi	12	36	Roosevelt	Roosevelt	NNP
work_4qabwxy7effildblswnw7mkrvi	12	37	Hospital	Hospital	NNP
work_4qabwxy7effildblswnw7mkrvi	12	38	Cen-	Cen-	NNP
work_4qabwxy7effildblswnw7mkrvi	12	39	ter	ter	NN
work_4qabwxy7effildblswnw7mkrvi	12	40	in	in	IN
work_4qabwxy7effildblswnw7mkrvi	12	41	New	New	NNP
work_4qabwxy7effildblswnw7mkrvi	12	42	York	York	NNP
work_4qabwxy7effildblswnw7mkrvi	12	43	City	City	NNP
work_4qabwxy7effildblswnw7mkrvi	12	44	,	,	,
work_4qabwxy7effildblswnw7mkrvi	12	45	New	New	NNP
work_4qabwxy7effildblswnw7mkrvi	12	46	York	York	NNP
work_4qabwxy7effildblswnw7mkrvi	12	47	.	.	.
work_4qabwxy7effildblswnw7mkrvi	13	1	Fixed	fix	VBN
work_4qabwxy7effildblswnw7mkrvi	13	2	-	-	HYPH
work_4qabwxy7effildblswnw7mkrvi	13	3	dose	dose	NN
work_4qabwxy7effildblswnw7mkrvi	13	4	combination	combination	NN
work_4qabwxy7effildblswnw7mkrvi	13	5	products	product	NNS
work_4qabwxy7effildblswnw7mkrvi	13	6	also	also	RB
work_4qabwxy7effildblswnw7mkrvi	13	7	hold	hold	VBP
work_4qabwxy7effildblswnw7mkrvi	13	8	great	great	JJ
work_4qabwxy7effildblswnw7mkrvi	13	9	appeal	appeal	NN
work_4qabwxy7effildblswnw7mkrvi	13	10	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	13	11	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	13	12	pharma-	pharma-	JJ
work_4qabwxy7effildblswnw7mkrvi	13	13	ceutical	ceutical	JJ
work_4qabwxy7effildblswnw7mkrvi	13	14	industry	industry	NN
work_4qabwxy7effildblswnw7mkrvi	13	15	,	,	,
work_4qabwxy7effildblswnw7mkrvi	13	16	suggests	suggest	VBZ
work_4qabwxy7effildblswnw7mkrvi	13	17	Messerli	Messerli	NNP
work_4qabwxy7effildblswnw7mkrvi	13	18	.	.	.
work_4qabwxy7effildblswnw7mkrvi	14	1	It	-PRON-	PRP
work_4qabwxy7effildblswnw7mkrvi	14	2	can	can	MD
work_4qabwxy7effildblswnw7mkrvi	14	3	sometimes	sometimes	RB
work_4qabwxy7effildblswnw7mkrvi	14	4	cost	cost	VB
work_4qabwxy7effildblswnw7mkrvi	14	5	in	in	IN
work_4qabwxy7effildblswnw7mkrvi	14	6	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	14	7	neighbour-	neighbour-	JJ
work_4qabwxy7effildblswnw7mkrvi	14	8	hood	hood	NN
work_4qabwxy7effildblswnw7mkrvi	14	9	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	14	10	US$	us$	$
work_4qabwxy7effildblswnw7mkrvi	14	11	1	1	CD
work_4qabwxy7effildblswnw7mkrvi	14	12	billion	billion	CD
work_4qabwxy7effildblswnw7mkrvi	14	13	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	14	14	bring	bring	VB
work_4qabwxy7effildblswnw7mkrvi	14	15	a	a	DT
work_4qabwxy7effildblswnw7mkrvi	14	16	new	new	JJ
work_4qabwxy7effildblswnw7mkrvi	14	17	drug	drug	NN
work_4qabwxy7effildblswnw7mkrvi	14	18	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	14	19	market	market	NN
work_4qabwxy7effildblswnw7mkrvi	14	20	,	,	,
work_4qabwxy7effildblswnw7mkrvi	14	21	he	-PRON-	PRP
work_4qabwxy7effildblswnw7mkrvi	14	22	notes	note	VBZ
work_4qabwxy7effildblswnw7mkrvi	14	23	,	,	,
work_4qabwxy7effildblswnw7mkrvi	14	24	but	but	CC
work_4qabwxy7effildblswnw7mkrvi	14	25	it	-PRON-	PRP
work_4qabwxy7effildblswnw7mkrvi	14	26	may	may	MD
work_4qabwxy7effildblswnw7mkrvi	14	27	cost	cost	VB
work_4qabwxy7effildblswnw7mkrvi	14	28	only	only	RB
work_4qabwxy7effildblswnw7mkrvi	14	29	a	a	DT
work_4qabwxy7effildblswnw7mkrvi	14	30	quarter	quarter	NN
work_4qabwxy7effildblswnw7mkrvi	14	31	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	14	32	that	that	DT
work_4qabwxy7effildblswnw7mkrvi	14	33	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	14	34	release	release	VB
work_4qabwxy7effildblswnw7mkrvi	14	35	a	a	DT
work_4qabwxy7effildblswnw7mkrvi	14	36	combination	combination	NN
work_4qabwxy7effildblswnw7mkrvi	14	37	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	14	38	existing	exist	VBG
work_4qabwxy7effildblswnw7mkrvi	14	39	drugs	drug	NNS
work_4qabwxy7effildblswnw7mkrvi	14	40	.	.	.
work_4qabwxy7effildblswnw7mkrvi	15	1	“	"	``
work_4qabwxy7effildblswnw7mkrvi	15	2	It	-PRON-	PRP
work_4qabwxy7effildblswnw7mkrvi	15	3	’s	’	VBZ
work_4qabwxy7effildblswnw7mkrvi	15	4	hard	hard	JJ
work_4qabwxy7effildblswnw7mkrvi	15	5	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	15	6	come	come	VB
work_4qabwxy7effildblswnw7mkrvi	15	7	up	up	RP
work_4qabwxy7effildblswnw7mkrvi	15	8	with	with	IN
work_4qabwxy7effildblswnw7mkrvi	15	9	new	new	JJ
work_4qabwxy7effildblswnw7mkrvi	15	10	drugs	drug	NNS
work_4qabwxy7effildblswnw7mkrvi	15	11	,	,	,
work_4qabwxy7effildblswnw7mkrvi	15	12	”	"	''
work_4qabwxy7effildblswnw7mkrvi	15	13	says	say	VBZ
work_4qabwxy7effildblswnw7mkrvi	15	14	Messerli	Messerli	NNP
work_4qabwxy7effildblswnw7mkrvi	15	15	.	.	.
work_4qabwxy7effildblswnw7mkrvi	16	1	“	"	``
work_4qabwxy7effildblswnw7mkrvi	16	2	It	-PRON-	PRP
work_4qabwxy7effildblswnw7mkrvi	16	3	’s	’	VBZ
work_4qabwxy7effildblswnw7mkrvi	16	4	easier	easy	JJR
work_4qabwxy7effildblswnw7mkrvi	16	5	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	16	6	com-	com-	VB
work_4qabwxy7effildblswnw7mkrvi	16	7	bine	bine	NN
work_4qabwxy7effildblswnw7mkrvi	16	8	drugs	drug	NNS
work_4qabwxy7effildblswnw7mkrvi	16	9	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	16	10	make	make	VB
work_4qabwxy7effildblswnw7mkrvi	16	11	money	money	NN
work_4qabwxy7effildblswnw7mkrvi	16	12	that	that	DT
work_4qabwxy7effildblswnw7mkrvi	16	13	way	way	NN
work_4qabwxy7effildblswnw7mkrvi	16	14	.	.	.
work_4qabwxy7effildblswnw7mkrvi	16	15	”	"	''
work_4qabwxy7effildblswnw7mkrvi	16	16	Of	of	RB
work_4qabwxy7effildblswnw7mkrvi	16	17	course	course	RB
work_4qabwxy7effildblswnw7mkrvi	16	18	,	,	,
work_4qabwxy7effildblswnw7mkrvi	16	19	drug	drug	NN
work_4qabwxy7effildblswnw7mkrvi	16	20	manufacturers	manufacturer	NNS
work_4qabwxy7effildblswnw7mkrvi	16	21	that	that	WDT
work_4qabwxy7effildblswnw7mkrvi	16	22	produce	produce	VBP
work_4qabwxy7effildblswnw7mkrvi	16	23	combination	combination	NN
work_4qabwxy7effildblswnw7mkrvi	16	24	products	product	NNS
work_4qabwxy7effildblswnw7mkrvi	16	25	must	must	MD
work_4qabwxy7effildblswnw7mkrvi	16	26	still	still	RB
work_4qabwxy7effildblswnw7mkrvi	16	27	go	go	VB
work_4qabwxy7effildblswnw7mkrvi	16	28	through	through	IN
work_4qabwxy7effildblswnw7mkrvi	16	29	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	16	30	regular	regular	JJ
work_4qabwxy7effildblswnw7mkrvi	16	31	approval	approval	NN
work_4qabwxy7effildblswnw7mkrvi	16	32	process	process	NN
work_4qabwxy7effildblswnw7mkrvi	16	33	,	,	,
work_4qabwxy7effildblswnw7mkrvi	16	34	even	even	RB
work_4qabwxy7effildblswnw7mkrvi	16	35	if	if	IN
work_4qabwxy7effildblswnw7mkrvi	16	36	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	16	37	individual	individual	JJ
work_4qabwxy7effildblswnw7mkrvi	16	38	compo-	compo-	NN
work_4qabwxy7effildblswnw7mkrvi	16	39	nents	nent	NNS
work_4qabwxy7effildblswnw7mkrvi	16	40	have	have	VBP
work_4qabwxy7effildblswnw7mkrvi	16	41	already	already	RB
work_4qabwxy7effildblswnw7mkrvi	16	42	been	be	VBN
work_4qabwxy7effildblswnw7mkrvi	16	43	approved	approve	VBN
work_4qabwxy7effildblswnw7mkrvi	16	44	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	16	45	sale	sale	NN
work_4qabwxy7effildblswnw7mkrvi	16	46	.	.	.
work_4qabwxy7effildblswnw7mkrvi	17	1	In	in	IN
work_4qabwxy7effildblswnw7mkrvi	17	2	Canada	Canada	NNP
work_4qabwxy7effildblswnw7mkrvi	17	3	,	,	,
work_4qabwxy7effildblswnw7mkrvi	17	4	manufacturers	manufacturer	NNS
work_4qabwxy7effildblswnw7mkrvi	17	5	must	must	MD
work_4qabwxy7effildblswnw7mkrvi	17	6	submit	submit	VB
work_4qabwxy7effildblswnw7mkrvi	17	7	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	17	8	same	same	JJ
work_4qabwxy7effildblswnw7mkrvi	17	9	level	level	NN
work_4qabwxy7effildblswnw7mkrvi	17	10	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	17	11	evidence	evidence	NN
work_4qabwxy7effildblswnw7mkrvi	17	12	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	17	13	efficacy	efficacy	NN
work_4qabwxy7effildblswnw7mkrvi	17	14	,	,	,
work_4qabwxy7effildblswnw7mkrvi	17	15	safety	safety	NN
work_4qabwxy7effildblswnw7mkrvi	17	16	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	17	17	quality	quality	NN
work_4qabwxy7effildblswnw7mkrvi	17	18	as	as	IN
work_4qabwxy7effildblswnw7mkrvi	17	19	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	17	20	single	single	JJ
work_4qabwxy7effildblswnw7mkrvi	17	21	-component	-component	JJ
work_4qabwxy7effildblswnw7mkrvi	17	22	drugs	drug	NNS
work_4qabwxy7effildblswnw7mkrvi	17	23	.	.	.
work_4qabwxy7effildblswnw7mkrvi	18	1	“	"	``
work_4qabwxy7effildblswnw7mkrvi	18	2	All	all	DT
work_4qabwxy7effildblswnw7mkrvi	18	3	drug	drug	NN
work_4qabwxy7effildblswnw7mkrvi	18	4	submissions	submission	NNS
work_4qabwxy7effildblswnw7mkrvi	18	5	must	must	MD
work_4qabwxy7effildblswnw7mkrvi	18	6	undergo	undergo	VB
work_4qabwxy7effildblswnw7mkrvi	18	7	rigorous	rigorous	JJ
work_4qabwxy7effildblswnw7mkrvi	18	8	scrutiny	scrutiny	NN
work_4qabwxy7effildblswnw7mkrvi	18	9	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	18	10	satisfy	satisfy	VB
work_4qabwxy7effildblswnw7mkrvi	18	11	scientific	scientific	JJ
work_4qabwxy7effildblswnw7mkrvi	18	12	requirements	requirement	NNS
work_4qabwxy7effildblswnw7mkrvi	18	13	under	under	IN
work_4qabwxy7effildblswnw7mkrvi	18	14	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	18	15	Food	Food	NNP
work_4qabwxy7effildblswnw7mkrvi	18	16	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	18	17	Drugs	Drugs	NNP
work_4qabwxy7effildblswnw7mkrvi	18	18	Regulations	Regulations	NNPS
work_4qabwxy7effildblswnw7mkrvi	18	19	,	,	,
work_4qabwxy7effildblswnw7mkrvi	18	20	including	include	VBG
work_4qabwxy7effildblswnw7mkrvi	18	21	those	those	DT
work_4qabwxy7effildblswnw7mkrvi	18	22	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	18	23	fixed-	fixed-	JJ
work_4qabwxy7effildblswnw7mkrvi	18	24	dose	dose	JJ
work_4qabwxy7effildblswnw7mkrvi	18	25	drugs	drug	NNS
work_4qabwxy7effildblswnw7mkrvi	18	26	,	,	,
work_4qabwxy7effildblswnw7mkrvi	18	27	before	before	IN
work_4qabwxy7effildblswnw7mkrvi	18	28	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	18	29	drug	drug	NN
work_4qabwxy7effildblswnw7mkrvi	18	30	can	can	MD
work_4qabwxy7effildblswnw7mkrvi	18	31	be	be	VB
work_4qabwxy7effildblswnw7mkrvi	18	32	mar-	mar-	NNP
work_4qabwxy7effildblswnw7mkrvi	18	33	keted	kete	VBN
work_4qabwxy7effildblswnw7mkrvi	18	34	,	,	,
work_4qabwxy7effildblswnw7mkrvi	18	35	”	"	''
work_4qabwxy7effildblswnw7mkrvi	18	36	Olivia	Olivia	NNP
work_4qabwxy7effildblswnw7mkrvi	18	37	Caron	Caron	NNP
work_4qabwxy7effildblswnw7mkrvi	18	38	,	,	,
work_4qabwxy7effildblswnw7mkrvi	18	39	media	medium	NNS
work_4qabwxy7effildblswnw7mkrvi	18	40	relations	relation	NNS
work_4qabwxy7effildblswnw7mkrvi	18	41	officer	officer	NN
work_4qabwxy7effildblswnw7mkrvi	18	42	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	18	43	Health	Health	NNP
work_4qabwxy7effildblswnw7mkrvi	18	44	Canada	Canada	NNP
work_4qabwxy7effildblswnw7mkrvi	18	45	,	,	,
work_4qabwxy7effildblswnw7mkrvi	18	46	writes	write	VBZ
work_4qabwxy7effildblswnw7mkrvi	18	47	in	in	IN
work_4qabwxy7effildblswnw7mkrvi	18	48	an	an	DT
work_4qabwxy7effildblswnw7mkrvi	18	49	email	email	NN
work_4qabwxy7effildblswnw7mkrvi	18	50	.	.	.
work_4qabwxy7effildblswnw7mkrvi	19	1	“	"	``
work_4qabwxy7effildblswnw7mkrvi	19	2	The	the	DT
work_4qabwxy7effildblswnw7mkrvi	19	3	choice	choice	NN
work_4qabwxy7effildblswnw7mkrvi	19	4	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	19	5	a	a	DT
work_4qabwxy7effildblswnw7mkrvi	19	6	primary	primary	JJ
work_4qabwxy7effildblswnw7mkrvi	19	7	effi-	effi-	NN
work_4qabwxy7effildblswnw7mkrvi	19	8	cacy	cacy	NN
work_4qabwxy7effildblswnw7mkrvi	19	9	endpoint	endpoint	NN
work_4qabwxy7effildblswnw7mkrvi	19	10	in	in	IN
work_4qabwxy7effildblswnw7mkrvi	19	11	a	a	DT
work_4qabwxy7effildblswnw7mkrvi	19	12	randomized	randomized	JJ
work_4qabwxy7effildblswnw7mkrvi	19	13	clinical	clinical	JJ
work_4qabwxy7effildblswnw7mkrvi	19	14	trial	trial	NN
work_4qabwxy7effildblswnw7mkrvi	19	15	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	19	16	fixed	fix	VBN
work_4qabwxy7effildblswnw7mkrvi	19	17	-	-	HYPH
work_4qabwxy7effildblswnw7mkrvi	19	18	dose	dose	NN
work_4qabwxy7effildblswnw7mkrvi	19	19	drugs	drug	NNS
work_4qabwxy7effildblswnw7mkrvi	19	20	is	be	VBZ
work_4qabwxy7effildblswnw7mkrvi	19	21	based	base	VBN
work_4qabwxy7effildblswnw7mkrvi	19	22	on	on	IN
work_4qabwxy7effildblswnw7mkrvi	19	23	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	19	24	same	same	JJ
work_4qabwxy7effildblswnw7mkrvi	19	25	standards	standard	NNS
work_4qabwxy7effildblswnw7mkrvi	19	26	established	establish	VBN
work_4qabwxy7effildblswnw7mkrvi	19	27	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	19	28	sin-	sin-	JJ
work_4qabwxy7effildblswnw7mkrvi	19	29	gle	gle	JJ
work_4qabwxy7effildblswnw7mkrvi	19	30	component	component	NN
work_4qabwxy7effildblswnw7mkrvi	19	31	products	product	NNS
work_4qabwxy7effildblswnw7mkrvi	19	32	.	.	.
work_4qabwxy7effildblswnw7mkrvi	19	33	”	"	''
work_4qabwxy7effildblswnw7mkrvi	19	34	In	in	IN
work_4qabwxy7effildblswnw7mkrvi	19	35	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	19	36	United	United	NNP
work_4qabwxy7effildblswnw7mkrvi	19	37	States	States	NNP
work_4qabwxy7effildblswnw7mkrvi	19	38	,	,	,
work_4qabwxy7effildblswnw7mkrvi	19	39	manufacturers	manufacturer	NNS
work_4qabwxy7effildblswnw7mkrvi	19	40	must	must	MD
work_4qabwxy7effildblswnw7mkrvi	19	41	present	present	VB
work_4qabwxy7effildblswnw7mkrvi	19	42	efficacy	efficacy	NN
work_4qabwxy7effildblswnw7mkrvi	19	43	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	19	44	safety	safety	NN
work_4qabwxy7effildblswnw7mkrvi	19	45	data	datum	NNS
work_4qabwxy7effildblswnw7mkrvi	19	46	to	to	IN
work_4qabwxy7effildblswnw7mkrvi	19	47	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	19	48	Food	Food	NNP
work_4qabwxy7effildblswnw7mkrvi	19	49	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	19	50	Drug	Drug	NNP
work_4qabwxy7effildblswnw7mkrvi	19	51	Administration	Administration	NNP
work_4qabwxy7effildblswnw7mkrvi	19	52	(	(	-LRB-
work_4qabwxy7effildblswnw7mkrvi	19	53	FDA	FDA	NNP
work_4qabwxy7effildblswnw7mkrvi	19	54	)	)	-RRB-
work_4qabwxy7effildblswnw7mkrvi	19	55	.	.	.
work_4qabwxy7effildblswnw7mkrvi	20	1	If	if	IN
work_4qabwxy7effildblswnw7mkrvi	20	2	sufficient	sufficient	JJ
work_4qabwxy7effildblswnw7mkrvi	20	3	data	data	NN
work_4qabwxy7effildblswnw7mkrvi	20	4	exists	exist	VBZ
work_4qabwxy7effildblswnw7mkrvi	20	5	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	20	6	each	each	DT
work_4qabwxy7effildblswnw7mkrvi	20	7	individual	individual	JJ
work_4qabwxy7effildblswnw7mkrvi	20	8	component	component	NN
work_4qabwxy7effildblswnw7mkrvi	20	9	,	,	,
work_4qabwxy7effildblswnw7mkrvi	20	10	however	however	RB
work_4qabwxy7effildblswnw7mkrvi	20	11	,	,	,
work_4qabwxy7effildblswnw7mkrvi	20	12	drug	drug	NN
work_4qabwxy7effildblswnw7mkrvi	20	13	makers	maker	NNS
work_4qabwxy7effildblswnw7mkrvi	20	14	may	may	MD
work_4qabwxy7effildblswnw7mkrvi	20	15	or	or	CC
work_4qabwxy7effildblswnw7mkrvi	20	16	may	may	MD
work_4qabwxy7effildblswnw7mkrvi	20	17	not	not	RB
work_4qabwxy7effildblswnw7mkrvi	20	18	have	have	VB
work_4qabwxy7effildblswnw7mkrvi	20	19	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	20	20	con-	con-	VB
work_4qabwxy7effildblswnw7mkrvi	20	21	duct	duct	VB
work_4qabwxy7effildblswnw7mkrvi	20	22	additional	additional	JJ
work_4qabwxy7effildblswnw7mkrvi	20	23	studies	study	NNS
work_4qabwxy7effildblswnw7mkrvi	20	24	,	,	,
work_4qabwxy7effildblswnw7mkrvi	20	25	depending	depend	VBG
work_4qabwxy7effildblswnw7mkrvi	20	26	on	on	IN
work_4qabwxy7effildblswnw7mkrvi	20	27	several	several	JJ
work_4qabwxy7effildblswnw7mkrvi	20	28	factors	factor	NNS
work_4qabwxy7effildblswnw7mkrvi	20	29	.	.	.
work_4qabwxy7effildblswnw7mkrvi	21	1	For	for	IN
work_4qabwxy7effildblswnw7mkrvi	21	2	example	example	NN
work_4qabwxy7effildblswnw7mkrvi	21	3	,	,	,
work_4qabwxy7effildblswnw7mkrvi	21	4	new	new	JJ
work_4qabwxy7effildblswnw7mkrvi	21	5	research	research	NN
work_4qabwxy7effildblswnw7mkrvi	21	6	may	may	MD
work_4qabwxy7effildblswnw7mkrvi	21	7	be	be	VB
work_4qabwxy7effildblswnw7mkrvi	21	8	required	require	VBN
work_4qabwxy7effildblswnw7mkrvi	21	9	if	if	IN
work_4qabwxy7effildblswnw7mkrvi	21	10	there	there	EX
work_4qabwxy7effildblswnw7mkrvi	21	11	is	be	VBZ
work_4qabwxy7effildblswnw7mkrvi	21	12	potential	potential	JJ
work_4qabwxy7effildblswnw7mkrvi	21	13	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	21	14	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	21	15	active	active	JJ
work_4qabwxy7effildblswnw7mkrvi	21	16	agents	agent	NNS
work_4qabwxy7effildblswnw7mkrvi	21	17	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	21	18	interact	interact	VB
work_4qabwxy7effildblswnw7mkrvi	21	19	in	in	IN
work_4qabwxy7effildblswnw7mkrvi	21	20	a	a	DT
work_4qabwxy7effildblswnw7mkrvi	21	21	way	way	NN
work_4qabwxy7effildblswnw7mkrvi	21	22	that	that	WDT
work_4qabwxy7effildblswnw7mkrvi	21	23	could	could	MD
work_4qabwxy7effildblswnw7mkrvi	21	24	prove	prove	VB
work_4qabwxy7effildblswnw7mkrvi	21	25	harmful	harmful	JJ
work_4qabwxy7effildblswnw7mkrvi	21	26	,	,	,
work_4qabwxy7effildblswnw7mkrvi	21	27	or	or	CC
work_4qabwxy7effildblswnw7mkrvi	21	28	if	if	IN
work_4qabwxy7effildblswnw7mkrvi	21	29	there	there	EX
work_4qabwxy7effildblswnw7mkrvi	21	30	is	be	VBZ
work_4qabwxy7effildblswnw7mkrvi	21	31	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	21	32	possibility	possibility	NN
work_4qabwxy7effildblswnw7mkrvi	21	33	that	that	IN
work_4qabwxy7effildblswnw7mkrvi	21	34	one	one	CD
work_4qabwxy7effildblswnw7mkrvi	21	35	component	component	NN
work_4qabwxy7effildblswnw7mkrvi	21	36	could	could	MD
work_4qabwxy7effildblswnw7mkrvi	21	37	chemically	chemically	RB
work_4qabwxy7effildblswnw7mkrvi	21	38	modify	modify	VB
work_4qabwxy7effildblswnw7mkrvi	21	39	another	another	DT
work_4qabwxy7effildblswnw7mkrvi	21	40	component	component	NN
work_4qabwxy7effildblswnw7mkrvi	21	41	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	21	42	compromise	compromise	VB
work_4qabwxy7effildblswnw7mkrvi	21	43	its	-PRON-	PRP$
work_4qabwxy7effildblswnw7mkrvi	21	44	effectiveness	effectiveness	NN
work_4qabwxy7effildblswnw7mkrvi	21	45	.	.	.
work_4qabwxy7effildblswnw7mkrvi	22	1	But	but	CC
work_4qabwxy7effildblswnw7mkrvi	22	2	if	if	IN
work_4qabwxy7effildblswnw7mkrvi	22	3	there	there	EX
work_4qabwxy7effildblswnw7mkrvi	22	4	are	be	VBP
work_4qabwxy7effildblswnw7mkrvi	22	5	no	no	DT
work_4qabwxy7effildblswnw7mkrvi	22	6	apparent	apparent	JJ
work_4qabwxy7effildblswnw7mkrvi	22	7	safety	safety	NN
work_4qabwxy7effildblswnw7mkrvi	22	8	issues	issue	NNS
work_4qabwxy7effildblswnw7mkrvi	22	9	,	,	,
work_4qabwxy7effildblswnw7mkrvi	22	10	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	22	11	manufacturer	manufacturer	NN
work_4qabwxy7effildblswnw7mkrvi	22	12	may	may	MD
work_4qabwxy7effildblswnw7mkrvi	22	13	not	not	RB
work_4qabwxy7effildblswnw7mkrvi	22	14	have	have	VB
work_4qabwxy7effildblswnw7mkrvi	22	15	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	22	16	con-	con-	VB
work_4qabwxy7effildblswnw7mkrvi	22	17	duct	duct	VB
work_4qabwxy7effildblswnw7mkrvi	22	18	any	any	DT
work_4qabwxy7effildblswnw7mkrvi	22	19	additional	additional	JJ
work_4qabwxy7effildblswnw7mkrvi	22	20	research	research	NN
work_4qabwxy7effildblswnw7mkrvi	22	21	.	.	.
work_4qabwxy7effildblswnw7mkrvi	23	1	“	"	``
work_4qabwxy7effildblswnw7mkrvi	23	2	If	if	IN
work_4qabwxy7effildblswnw7mkrvi	23	3	existing	exist	VBG
work_4qabwxy7effildblswnw7mkrvi	23	4	clinical	clinical	JJ
work_4qabwxy7effildblswnw7mkrvi	23	5	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	23	6	nonclinical	nonclinical	JJ
work_4qabwxy7effildblswnw7mkrvi	23	7	safety	safety	NN
work_4qabwxy7effildblswnw7mkrvi	23	8	data	datum	NNS
work_4qabwxy7effildblswnw7mkrvi	23	9	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	23	10	each	each	DT
work_4qabwxy7effildblswnw7mkrvi	23	11	separate	separate	JJ
work_4qabwxy7effildblswnw7mkrvi	23	12	drug	drug	NN
work_4qabwxy7effildblswnw7mkrvi	23	13	or	or	CC
work_4qabwxy7effildblswnw7mkrvi	23	14	biologic	biologic	NN
work_4qabwxy7effildblswnw7mkrvi	23	15	are	be	VBP
work_4qabwxy7effildblswnw7mkrvi	23	16	sufficient	sufficient	JJ
work_4qabwxy7effildblswnw7mkrvi	23	17	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	23	18	support	support	VB
work_4qabwxy7effildblswnw7mkrvi	23	19	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	23	20	safety	safety	NN
work_4qabwxy7effildblswnw7mkrvi	23	21	or	or	CC
work_4qabwxy7effildblswnw7mkrvi	23	22	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	23	23	proposed	propose	VBN
work_4qabwxy7effildblswnw7mkrvi	23	24	new	new	JJ
work_4qabwxy7effildblswnw7mkrvi	23	25	indication	indication	NN
work_4qabwxy7effildblswnw7mkrvi	23	26	,	,	,
work_4qabwxy7effildblswnw7mkrvi	23	27	including	include	VBG
work_4qabwxy7effildblswnw7mkrvi	23	28	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	23	29	dose	dose	NN
work_4qabwxy7effildblswnw7mkrvi	23	30	,	,	,
work_4qabwxy7effildblswnw7mkrvi	23	31	dosing	dosing	NN
work_4qabwxy7effildblswnw7mkrvi	23	32	schedule	schedule	NN
work_4qabwxy7effildblswnw7mkrvi	23	33	,	,	,
work_4qabwxy7effildblswnw7mkrvi	23	34	duration	duration	NN
work_4qabwxy7effildblswnw7mkrvi	23	35	,	,	,
work_4qabwxy7effildblswnw7mkrvi	23	36	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	23	37	new	new	JJ
work_4qabwxy7effildblswnw7mkrvi	23	38	patient	patient	NN
work_4qabwxy7effildblswnw7mkrvi	23	39	population	population	NN
work_4qabwxy7effildblswnw7mkrvi	23	40	,	,	,
work_4qabwxy7effildblswnw7mkrvi	23	41	then	then	RB
work_4qabwxy7effildblswnw7mkrvi	23	42	addition	addition	NN
work_4qabwxy7effildblswnw7mkrvi	23	43	nonclinical	nonclinical	JJ
work_4qabwxy7effildblswnw7mkrvi	23	44	studies	study	NNS
work_4qabwxy7effildblswnw7mkrvi	23	45	may	may	MD
work_4qabwxy7effildblswnw7mkrvi	23	46	NewsCMAJ	NewsCMAJ	NNP
work_4qabwxy7effildblswnw7mkrvi	23	47	Reducing	reduce	VBG
work_4qabwxy7effildblswnw7mkrvi	23	48	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	23	49	“	"	``
work_4qabwxy7effildblswnw7mkrvi	23	50	pill	pill	NN
work_4qabwxy7effildblswnw7mkrvi	23	51	burden	burden	NNP
work_4qabwxy7effildblswnw7mkrvi	23	52	”	"	''
work_4qabwxy7effildblswnw7mkrvi	23	53	©	©	NNP
work_4qabwxy7effildblswnw7mkrvi	23	54	2012	2012	CD
work_4qabwxy7effildblswnw7mkrvi	23	55	Canadian	Canadian	NNP
work_4qabwxy7effildblswnw7mkrvi	23	56	Medical	Medical	NNP
work_4qabwxy7effildblswnw7mkrvi	23	57	Association	Association	NNP
work_4qabwxy7effildblswnw7mkrvi	23	58	or	or	CC
work_4qabwxy7effildblswnw7mkrvi	23	59	its	-PRON-	PRP$
work_4qabwxy7effildblswnw7mkrvi	23	60	licensors	licensor	NNS
work_4qabwxy7effildblswnw7mkrvi	23	61	CMAJ	CMAJ	NNP
work_4qabwxy7effildblswnw7mkrvi	23	62	,	,	,
work_4qabwxy7effildblswnw7mkrvi	23	63	February	February	NNP
work_4qabwxy7effildblswnw7mkrvi	23	64	7	7	CD
work_4qabwxy7effildblswnw7mkrvi	23	65	,	,	,
work_4qabwxy7effildblswnw7mkrvi	23	66	2012	2012	CD
work_4qabwxy7effildblswnw7mkrvi	23	67	,	,	,
work_4qabwxy7effildblswnw7mkrvi	23	68	184(2	184(2	CD
work_4qabwxy7effildblswnw7mkrvi	23	69	)	)	-RRB-
work_4qabwxy7effildblswnw7mkrvi	23	70	E117	e117	NN
work_4qabwxy7effildblswnw7mkrvi	23	71	Some	some	DT
work_4qabwxy7effildblswnw7mkrvi	23	72	patients	patient	NNS
work_4qabwxy7effildblswnw7mkrvi	23	73	find	find	VBP
work_4qabwxy7effildblswnw7mkrvi	23	74	their	-PRON-	PRP$
work_4qabwxy7effildblswnw7mkrvi	23	75	pill	pill	NN
work_4qabwxy7effildblswnw7mkrvi	23	76	regimen	regiman	NNS
work_4qabwxy7effildblswnw7mkrvi	23	77	confusing	confusing	JJ
work_4qabwxy7effildblswnw7mkrvi	23	78	.	.	.
work_4qabwxy7effildblswnw7mkrvi	24	1	©	©	LS
work_4qabwxy7effildblswnw7mkrvi	24	2	2	2	CD
work_4qabwxy7effildblswnw7mkrvi	24	3	0	0	CD
work_4qabwxy7effildblswnw7mkrvi	24	4	1	1	CD
work_4qabwxy7effildblswnw7mkrvi	24	5	1	1	CD
work_4qabwxy7effildblswnw7mkrvi	24	6	T	t	NN
work_4qabwxy7effildblswnw7mkrvi	24	7	h	h	NN
work_4qabwxy7effildblswnw7mkrvi	24	8	in	in	IN
work_4qabwxy7effildblswnw7mkrvi	24	9	k	k	NNP
work_4qabwxy7effildblswnw7mkrvi	24	10	st	st	NNP
work_4qabwxy7effildblswnw7mkrvi	24	11	o	o	NNP
work_4qabwxy7effildblswnw7mkrvi	24	12	ck	ck	NNP
work_4qabwxy7effildblswnw7mkrvi	24	13	News	News	NNP
work_4qabwxy7effildblswnw7mkrvi	24	14	not	not	RB
work_4qabwxy7effildblswnw7mkrvi	24	15	be	be	VB
work_4qabwxy7effildblswnw7mkrvi	24	16	needed	need	VBN
work_4qabwxy7effildblswnw7mkrvi	24	17	,	,	,
work_4qabwxy7effildblswnw7mkrvi	24	18	”	"	''
work_4qabwxy7effildblswnw7mkrvi	24	19	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	24	20	FDA	FDA	NNP
work_4qabwxy7effildblswnw7mkrvi	24	21	states	state	NNS
work_4qabwxy7effildblswnw7mkrvi	24	22	in	in	IN
work_4qabwxy7effildblswnw7mkrvi	24	23	a	a	DT
work_4qabwxy7effildblswnw7mkrvi	24	24	guidance	guidance	NN
work_4qabwxy7effildblswnw7mkrvi	24	25	document	document	NN
work_4qabwxy7effildblswnw7mkrvi	24	26	(	(	-LRB-
work_4qabwxy7effildblswnw7mkrvi	24	27	www.fda.gov	www.fda.gov	NNP
work_4qabwxy7effildblswnw7mkrvi	24	28	/downloads	/downloads	,
work_4qabwxy7effildblswnw7mkrvi	24	29	/	/	SYM
work_4qabwxy7effildblswnw7mkrvi	24	30	Drugs	Drugs	NNP
work_4qabwxy7effildblswnw7mkrvi	24	31	/	/	SYM
work_4qabwxy7effildblswnw7mkrvi	24	32	GuidanceCompliance	GuidanceCompliance	NNP
work_4qabwxy7effildblswnw7mkrvi	24	33	RegulatoryInformation	RegulatoryInformation	NNP
work_4qabwxy7effildblswnw7mkrvi	24	34	/	/	SYM
work_4qabwxy7effildblswnw7mkrvi	24	35	Guidances	Guidances	NNP
work_4qabwxy7effildblswnw7mkrvi	24	36	/	/	SYM
work_4qabwxy7effildblswnw7mkrvi	24	37	ucm	ucm	NNP
work_4qabwxy7effildblswnw7mkrvi	24	38	079243.pdf	079243.pdf	CD
work_4qabwxy7effildblswnw7mkrvi	24	39	)	)	-RRB-
work_4qabwxy7effildblswnw7mkrvi	24	40	.	.	.
work_4qabwxy7effildblswnw7mkrvi	25	1	In	in	IN
work_4qabwxy7effildblswnw7mkrvi	25	2	some	some	DT
work_4qabwxy7effildblswnw7mkrvi	25	3	situations	situation	NNS
work_4qabwxy7effildblswnw7mkrvi	25	4	,	,	,
work_4qabwxy7effildblswnw7mkrvi	25	5	FDA	FDA	NNP
work_4qabwxy7effildblswnw7mkrvi	25	6	may	may	MD
work_4qabwxy7effildblswnw7mkrvi	25	7	even	even	RB
work_4qabwxy7effildblswnw7mkrvi	25	8	accelerate	accelerate	VB
work_4qabwxy7effildblswnw7mkrvi	25	9	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	25	10	approval	approval	NN
work_4qabwxy7effildblswnw7mkrvi	25	11	process	process	NN
work_4qabwxy7effildblswnw7mkrvi	25	12	if	if	IN
work_4qabwxy7effildblswnw7mkrvi	25	13	suffi-	suffi-	NNP
work_4qabwxy7effildblswnw7mkrvi	25	14	cient	cient	NNP
work_4qabwxy7effildblswnw7mkrvi	25	15	data	data	NNP
work_4qabwxy7effildblswnw7mkrvi	25	16	exists	exist	VBZ
work_4qabwxy7effildblswnw7mkrvi	25	17	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	25	18	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	25	19	component	component	NN
work_4qabwxy7effildblswnw7mkrvi	25	20	drugs	drug	NNS
work_4qabwxy7effildblswnw7mkrvi	25	21	.	.	.
work_4qabwxy7effildblswnw7mkrvi	26	1	This	this	DT
work_4qabwxy7effildblswnw7mkrvi	26	2	appears	appear	VBZ
work_4qabwxy7effildblswnw7mkrvi	26	3	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	26	4	be	be	VB
work_4qabwxy7effildblswnw7mkrvi	26	5	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	26	6	case	case	NN
work_4qabwxy7effildblswnw7mkrvi	26	7	,	,	,
work_4qabwxy7effildblswnw7mkrvi	26	8	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	26	9	instance	instance	NN
work_4qabwxy7effildblswnw7mkrvi	26	10	,	,	,
work_4qabwxy7effildblswnw7mkrvi	26	11	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	26	12	fixed	fix	VBN
work_4qabwxy7effildblswnw7mkrvi	26	13	-	-	HYPH
work_4qabwxy7effildblswnw7mkrvi	26	14	dose	dose	VBN
work_4qabwxy7effildblswnw7mkrvi	26	15	combinations	combination	NNS
work_4qabwxy7effildblswnw7mkrvi	26	16	or	or	CC
work_4qabwxy7effildblswnw7mkrvi	26	17	copackaged	copackage	VBN
work_4qabwxy7effildblswnw7mkrvi	26	18	drug	drug	NN
work_4qabwxy7effildblswnw7mkrvi	26	19	products	product	NNS
work_4qabwxy7effildblswnw7mkrvi	26	20	made	make	VBN
work_4qabwxy7effildblswnw7mkrvi	26	21	from	from	IN
work_4qabwxy7effildblswnw7mkrvi	26	22	previously	previously	RB
work_4qabwxy7effildblswnw7mkrvi	26	23	approved	approve	VBN
work_4qabwxy7effildblswnw7mkrvi	26	24	antiretrovi-	antiretrovi-	NNP
work_4qabwxy7effildblswnw7mkrvi	26	25	rals	ral	NNS
work_4qabwxy7effildblswnw7mkrvi	26	26	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	26	27	treat	treat	VB
work_4qabwxy7effildblswnw7mkrvi	26	28	HIV	HIV	NNP
work_4qabwxy7effildblswnw7mkrvi	26	29	.	.	.
work_4qabwxy7effildblswnw7mkrvi	27	1	“	"	``
work_4qabwxy7effildblswnw7mkrvi	27	2	FDA	FDA	NNP
work_4qabwxy7effildblswnw7mkrvi	27	3	believes	believe	VBZ
work_4qabwxy7effildblswnw7mkrvi	27	4	that	that	IN
work_4qabwxy7effildblswnw7mkrvi	27	5	when	when	WRB
work_4qabwxy7effildblswnw7mkrvi	27	6	adequate	adequate	JJ
work_4qabwxy7effildblswnw7mkrvi	27	7	evidence	evidence	NN
work_4qabwxy7effildblswnw7mkrvi	27	8	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	27	9	safety	safety	NN
work_4qabwxy7effildblswnw7mkrvi	27	10	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	27	11	efficacy	efficacy	NN
work_4qabwxy7effildblswnw7mkrvi	27	12	exists	exist	VBZ
work_4qabwxy7effildblswnw7mkrvi	27	13	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	27	14	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	27	15	use	use	NN
work_4qabwxy7effildblswnw7mkrvi	27	16	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	27	17	combination	combination	NN
work_4qabwxy7effildblswnw7mkrvi	27	18	therapy	therapy	NN
work_4qabwxy7effildblswnw7mkrvi	27	19	with	with	IN
work_4qabwxy7effildblswnw7mkrvi	27	20	individually	individually	RB
work_4qabwxy7effildblswnw7mkrvi	27	21	approved	approve	VBN
work_4qabwxy7effildblswnw7mkrvi	27	22	HIV	HIV	NNP
work_4qabwxy7effildblswnw7mkrvi	27	23	drugs	drug	NNS
work_4qabwxy7effildblswnw7mkrvi	27	24	,	,	,
work_4qabwxy7effildblswnw7mkrvi	27	25	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	27	26	path	path	NN
work_4qabwxy7effildblswnw7mkrvi	27	27	to	to	IN
work_4qabwxy7effildblswnw7mkrvi	27	28	regulatory	regulatory	JJ
work_4qabwxy7effildblswnw7mkrvi	27	29	approval	approval	NN
work_4qabwxy7effildblswnw7mkrvi	27	30	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	27	31	an	an	DT
work_4qabwxy7effildblswnw7mkrvi	27	32	FDC	FDC	NNP
work_4qabwxy7effildblswnw7mkrvi	27	33	[	[	-LRB-
work_4qabwxy7effildblswnw7mkrvi	27	34	fixed	fix	VBN
work_4qabwxy7effildblswnw7mkrvi	27	35	-	-	HYPH
work_4qabwxy7effildblswnw7mkrvi	27	36	dose	dose	NN
work_4qabwxy7effildblswnw7mkrvi	27	37	combination	combination	NN
work_4qabwxy7effildblswnw7mkrvi	27	38	]	]	-RRB-
work_4qabwxy7effildblswnw7mkrvi	27	39	or	or	CC
work_4qabwxy7effildblswnw7mkrvi	27	40	co-	co-	VBN
work_4qabwxy7effildblswnw7mkrvi	27	41	packaged	package	VBN
work_4qabwxy7effildblswnw7mkrvi	27	42	configuration	configuration	NN
work_4qabwxy7effildblswnw7mkrvi	27	43	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	27	44	those	those	DT
work_4qabwxy7effildblswnw7mkrvi	27	45	drugs	drug	NNS
work_4qabwxy7effildblswnw7mkrvi	27	46	is	be	VBZ
work_4qabwxy7effildblswnw7mkrvi	27	47	straightforward	straightforward	JJ
work_4qabwxy7effildblswnw7mkrvi	27	48	,	,	,
work_4qabwxy7effildblswnw7mkrvi	27	49	”	"	''
work_4qabwxy7effildblswnw7mkrvi	27	50	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	27	51	agency	agency	NN
work_4qabwxy7effildblswnw7mkrvi	27	52	states	state	VBZ
work_4qabwxy7effildblswnw7mkrvi	27	53	in	in	IN
work_4qabwxy7effildblswnw7mkrvi	27	54	another	another	DT
work_4qabwxy7effildblswnw7mkrvi	27	55	guidance	guidance	NN
work_4qabwxy7effildblswnw7mkrvi	27	56	document	document	NN
work_4qabwxy7effildblswnw7mkrvi	27	57	(	(	-LRB-
work_4qabwxy7effildblswnw7mkrvi	27	58	www	www	NN
work_4qabwxy7effildblswnw7mkrvi	27	59	.fda	.fda	CD
work_4qabwxy7effildblswnw7mkrvi	27	60	.gov	.gov	.
work_4qabwxy7effildblswnw7mkrvi	27	61	/	/	SYM
work_4qabwxy7effildblswnw7mkrvi	27	62	downloads	download	NNS
work_4qabwxy7effildblswnw7mkrvi	27	63	/	/	SYM
work_4qabwxy7effildblswnw7mkrvi	27	64	Drugs	Drugs	NNPS
work_4qabwxy7effildblswnw7mkrvi	27	65	/	/	SYM
work_4qabwxy7effildblswnw7mkrvi	27	66	Guidance	Guidance	NNP
work_4qabwxy7effildblswnw7mkrvi	27	67	ComplianceRegulatoryInformation	complianceregulatoryinformation	NN
work_4qabwxy7effildblswnw7mkrvi	27	68	/Guidances	/guidance	NNS
work_4qabwxy7effildblswnw7mkrvi	27	69	/	/	SYM
work_4qabwxy7effildblswnw7mkrvi	27	70	UCM079742.pdf	ucm079742.pdf	NN
work_4qabwxy7effildblswnw7mkrvi	27	71	)	)	-RRB-
work_4qabwxy7effildblswnw7mkrvi	27	72	.	.	.
work_4qabwxy7effildblswnw7mkrvi	28	1	“	"	``
work_4qabwxy7effildblswnw7mkrvi	28	2	FDA	FDA	NNP
work_4qabwxy7effildblswnw7mkrvi	28	3	is	be	VBZ
work_4qabwxy7effildblswnw7mkrvi	28	4	prepared	prepared	JJ
work_4qabwxy7effildblswnw7mkrvi	28	5	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	28	6	move	move	VB
work_4qabwxy7effildblswnw7mkrvi	28	7	swiftly	swiftly	RB
work_4qabwxy7effildblswnw7mkrvi	28	8	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	28	9	evaluate	evaluate	VB
work_4qabwxy7effildblswnw7mkrvi	28	10	such	such	JJ
work_4qabwxy7effildblswnw7mkrvi	28	11	products	product	NNS
work_4qabwxy7effildblswnw7mkrvi	28	12	when	when	WRB
work_4qabwxy7effildblswnw7mkrvi	28	13	applications	application	NNS
work_4qabwxy7effildblswnw7mkrvi	28	14	are	be	VBP
work_4qabwxy7effildblswnw7mkrvi	28	15	submitted	submit	VBN
work_4qabwxy7effildblswnw7mkrvi	28	16	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	28	17	approval	approval	NN
work_4qabwxy7effildblswnw7mkrvi	28	18	.	.	.
work_4qabwxy7effildblswnw7mkrvi	28	19	”	"	''
work_4qabwxy7effildblswnw7mkrvi	28	20	This	this	DT
work_4qabwxy7effildblswnw7mkrvi	28	21	is	be	VBZ
work_4qabwxy7effildblswnw7mkrvi	28	22	good	good	JJ
work_4qabwxy7effildblswnw7mkrvi	28	23	news	news	NN
work_4qabwxy7effildblswnw7mkrvi	28	24	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	28	25	people	people	NNS
work_4qabwxy7effildblswnw7mkrvi	28	26	with	with	IN
work_4qabwxy7effildblswnw7mkrvi	28	27	certain	certain	JJ
work_4qabwxy7effildblswnw7mkrvi	28	28	conditions	condition	NNS
work_4qabwxy7effildblswnw7mkrvi	28	29	,	,	,
work_4qabwxy7effildblswnw7mkrvi	28	30	such	such	JJ
work_4qabwxy7effildblswnw7mkrvi	28	31	as	as	IN
work_4qabwxy7effildblswnw7mkrvi	28	32	glaucoma	glaucoma	NN
work_4qabwxy7effildblswnw7mkrvi	28	33	,	,	,
work_4qabwxy7effildblswnw7mkrvi	28	34	who	who	WP
work_4qabwxy7effildblswnw7mkrvi	28	35	have	have	VBP
work_4qabwxy7effildblswnw7mkrvi	28	36	been	be	VBN
work_4qabwxy7effildblswnw7mkrvi	28	37	shown	show	VBN
work_4qabwxy7effildblswnw7mkrvi	28	38	to	to	IN
work_4qabwxy7effildblswnw7mkrvi	28	39	not	not	RB
work_4qabwxy7effildblswnw7mkrvi	28	40	only	only	RB
work_4qabwxy7effildblswnw7mkrvi	28	41	better	well	RBR
work_4qabwxy7effildblswnw7mkrvi	28	42	comply	comply	VB
work_4qabwxy7effildblswnw7mkrvi	28	43	with	with	IN
work_4qabwxy7effildblswnw7mkrvi	28	44	fixed	fix	VBN
work_4qabwxy7effildblswnw7mkrvi	28	45	-	-	HYPH
work_4qabwxy7effildblswnw7mkrvi	28	46	dose	dose	NN
work_4qabwxy7effildblswnw7mkrvi	28	47	combination	combination	NN
work_4qabwxy7effildblswnw7mkrvi	28	48	drug	drug	NN
work_4qabwxy7effildblswnw7mkrvi	28	49	regimens	regimen	VBZ
work_4qabwxy7effildblswnw7mkrvi	28	50	but	but	CC
work_4qabwxy7effildblswnw7mkrvi	28	51	also	also	RB
work_4qabwxy7effildblswnw7mkrvi	28	52	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	28	53	save	save	VB
work_4qabwxy7effildblswnw7mkrvi	28	54	money	money	NN
work_4qabwxy7effildblswnw7mkrvi	28	55	while	while	IN
work_4qabwxy7effildblswnw7mkrvi	28	56	reducing	reduce	VBG
work_4qabwxy7effildblswnw7mkrvi	28	57	their	-PRON-	PRP$
work_4qabwxy7effildblswnw7mkrvi	28	58	pill	pill	NN
work_4qabwxy7effildblswnw7mkrvi	28	59	burden	burden	NN
work_4qabwxy7effildblswnw7mkrvi	28	60	,	,	,
work_4qabwxy7effildblswnw7mkrvi	28	61	according	accord	VBG
work_4qabwxy7effildblswnw7mkrvi	28	62	to	to	IN
work_4qabwxy7effildblswnw7mkrvi	28	63	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	28	64	American	American	NNP
work_4qabwxy7effildblswnw7mkrvi	28	65	Academy	Academy	NNP
work_4qabwxy7effildblswnw7mkrvi	28	66	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	28	67	Ophthalmology	Ophthalmology	NNP
work_4qabwxy7effildblswnw7mkrvi	28	68	(	(	-LRB-
work_4qabwxy7effildblswnw7mkrvi	28	69	www.oculist.net	www.oculist.net	NNP
work_4qabwxy7effildblswnw7mkrvi	28	70	/Soft	/Soft	NFP
work_4qabwxy7effildblswnw7mkrvi	28	71	/ShowSoftDown.asp?UrlID=1&SoftID	/ShowSoftDown.asp?UrlID=1&SoftID	.
work_4qabwxy7effildblswnw7mkrvi	28	72	=	=	SYM
work_4qabwxy7effildblswnw7mkrvi	28	73	377#page=162	377#page=162	CD
work_4qabwxy7effildblswnw7mkrvi	28	74	)	)	-RRB-
work_4qabwxy7effildblswnw7mkrvi	28	75	.	.	.
work_4qabwxy7effildblswnw7mkrvi	29	1	Those	those	DT
work_4qabwxy7effildblswnw7mkrvi	29	2	benefits	benefit	NNS
work_4qabwxy7effildblswnw7mkrvi	29	3	,	,	,
work_4qabwxy7effildblswnw7mkrvi	29	4	though	though	RB
work_4qabwxy7effildblswnw7mkrvi	29	5	,	,	,
work_4qabwxy7effildblswnw7mkrvi	29	6	may	may	MD
work_4qabwxy7effildblswnw7mkrvi	29	7	come	come	VB
work_4qabwxy7effildblswnw7mkrvi	29	8	at	at	IN
work_4qabwxy7effildblswnw7mkrvi	29	9	a	a	DT
work_4qabwxy7effildblswnw7mkrvi	29	10	cost	cost	NN
work_4qabwxy7effildblswnw7mkrvi	29	11	.	.	.
work_4qabwxy7effildblswnw7mkrvi	30	1	“	"	``
work_4qabwxy7effildblswnw7mkrvi	30	2	In	in	IN
work_4qabwxy7effildblswnw7mkrvi	30	3	an	an	DT
work_4qabwxy7effildblswnw7mkrvi	30	4	era	era	NN
work_4qabwxy7effildblswnw7mkrvi	30	5	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	30	6	many	many	JJ
work_4qabwxy7effildblswnw7mkrvi	30	7	drug	drug	NN
work_4qabwxy7effildblswnw7mkrvi	30	8	choices	choice	NNS
work_4qabwxy7effildblswnw7mkrvi	30	9	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	30	10	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	30	11	ability	ability	NN
work_4qabwxy7effildblswnw7mkrvi	30	12	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	30	13	individualize	individualize	VB
work_4qabwxy7effildblswnw7mkrvi	30	14	patient	patient	NN
work_4qabwxy7effildblswnw7mkrvi	30	15	care	care	NN
work_4qabwxy7effildblswnw7mkrvi	30	16	as	as	IN
work_4qabwxy7effildblswnw7mkrvi	30	17	never	never	RB
work_4qabwxy7effildblswnw7mkrvi	30	18	before	before	RB
work_4qabwxy7effildblswnw7mkrvi	30	19	,	,	,
work_4qabwxy7effildblswnw7mkrvi	30	20	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	30	21	fixed	fix	VBN
work_4qabwxy7effildblswnw7mkrvi	30	22	combinations	combination	NNS
work_4qabwxy7effildblswnw7mkrvi	30	23	limit	limit	VBP
work_4qabwxy7effildblswnw7mkrvi	30	24	clinicians	clinician	NNS
work_4qabwxy7effildblswnw7mkrvi	30	25	’	’	POS
work_4qabwxy7effildblswnw7mkrvi	30	26	ability	ability	NN
work_4qabwxy7effildblswnw7mkrvi	30	27	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	30	28	customize	customize	VB
work_4qabwxy7effildblswnw7mkrvi	30	29	dosing	dosing	NN
work_4qabwxy7effildblswnw7mkrvi	30	30	regimens	regimen	NNS
work_4qabwxy7effildblswnw7mkrvi	30	31	,	,	,
work_4qabwxy7effildblswnw7mkrvi	30	32	”	"	''
work_4qabwxy7effildblswnw7mkrvi	30	33	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	30	34	document	document	NN
work_4qabwxy7effildblswnw7mkrvi	30	35	states	state	NNS
work_4qabwxy7effildblswnw7mkrvi	30	36	.	.	.
work_4qabwxy7effildblswnw7mkrvi	31	1	“	"	``
work_4qabwxy7effildblswnw7mkrvi	31	2	Unless	unless	IN
work_4qabwxy7effildblswnw7mkrvi	31	3	prescribed	prescribe	VBN
work_4qabwxy7effildblswnw7mkrvi	31	4	with	with	IN
work_4qabwxy7effildblswnw7mkrvi	31	5	caution	caution	NN
work_4qabwxy7effildblswnw7mkrvi	31	6	,	,	,
work_4qabwxy7effildblswnw7mkrvi	31	7	fixed-	fixed-	JJ
work_4qabwxy7effildblswnw7mkrvi	31	8	combination	combination	NN
work_4qabwxy7effildblswnw7mkrvi	31	9	drugs	drug	NNS
work_4qabwxy7effildblswnw7mkrvi	31	10	may	may	MD
work_4qabwxy7effildblswnw7mkrvi	31	11	result	result	VB
work_4qabwxy7effildblswnw7mkrvi	31	12	in	in	IN
work_4qabwxy7effildblswnw7mkrvi	31	13	overtreatment	overtreatment	NN
work_4qabwxy7effildblswnw7mkrvi	31	14	for	for	IN
work_4qabwxy7effildblswnw7mkrvi	31	15	patients	patient	NNS
work_4qabwxy7effildblswnw7mkrvi	31	16	who	who	WP
work_4qabwxy7effildblswnw7mkrvi	31	17	may	may	MD
work_4qabwxy7effildblswnw7mkrvi	31	18	be	be	VB
work_4qabwxy7effildblswnw7mkrvi	31	19	controlled	control	VBN
work_4qabwxy7effildblswnw7mkrvi	31	20	with	with	IN
work_4qabwxy7effildblswnw7mkrvi	31	21	a	a	DT
work_4qabwxy7effildblswnw7mkrvi	31	22	single	single	JJ
work_4qabwxy7effildblswnw7mkrvi	31	23	agent	agent	NN
work_4qabwxy7effildblswnw7mkrvi	31	24	or	or	CC
work_4qabwxy7effildblswnw7mkrvi	31	25	fewer	few	JJR
work_4qabwxy7effildblswnw7mkrvi	31	26	doses	dose	NNS
work_4qabwxy7effildblswnw7mkrvi	31	27	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	31	28	combined	combine	VBN
work_4qabwxy7effildblswnw7mkrvi	31	29	medications	medication	NNS
work_4qabwxy7effildblswnw7mkrvi	31	30	if	if	IN
work_4qabwxy7effildblswnw7mkrvi	31	31	dosed	dose	VBN
work_4qabwxy7effildblswnw7mkrvi	31	32	concomitantly	concomitantly	RB
work_4qabwxy7effildblswnw7mkrvi	31	33	.	.	.
work_4qabwxy7effildblswnw7mkrvi	31	34	”	"	''
work_4qabwxy7effildblswnw7mkrvi	31	35	Still	still	RB
work_4qabwxy7effildblswnw7mkrvi	31	36	,	,	,
work_4qabwxy7effildblswnw7mkrvi	31	37	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	31	38	primary	primary	JJ
work_4qabwxy7effildblswnw7mkrvi	31	39	benefit	benefit	NN
work_4qabwxy7effildblswnw7mkrvi	31	40	of	of	IN
work_4qabwxy7effildblswnw7mkrvi	31	41	combina-	combina-	NNP
work_4qabwxy7effildblswnw7mkrvi	31	42	tion	tion	NN
work_4qabwxy7effildblswnw7mkrvi	31	43	drugs	drug	NNS
work_4qabwxy7effildblswnw7mkrvi	31	44	—	—	:
work_4qabwxy7effildblswnw7mkrvi	31	45	a	a	DT
work_4qabwxy7effildblswnw7mkrvi	31	46	substantial	substantial	JJ
work_4qabwxy7effildblswnw7mkrvi	31	47	increase	increase	NN
work_4qabwxy7effildblswnw7mkrvi	31	48	adherence	adherence	NN
work_4qabwxy7effildblswnw7mkrvi	31	49	to	to	IN
work_4qabwxy7effildblswnw7mkrvi	31	50	treatment	treatment	NN
work_4qabwxy7effildblswnw7mkrvi	31	51	—	—	:
work_4qabwxy7effildblswnw7mkrvi	31	52	may	may	MD
work_4qabwxy7effildblswnw7mkrvi	31	53	out-	out-	RB
work_4qabwxy7effildblswnw7mkrvi	31	54	weigh	weigh	VB
work_4qabwxy7effildblswnw7mkrvi	31	55	the	the	DT
work_4qabwxy7effildblswnw7mkrvi	31	56	potential	potential	JJ
work_4qabwxy7effildblswnw7mkrvi	31	57	problems	problem	NNS
work_4qabwxy7effildblswnw7mkrvi	31	58	as	as	IN
work_4qabwxy7effildblswnw7mkrvi	31	59	aging	age	VBG
work_4qabwxy7effildblswnw7mkrvi	31	60	populations	population	NNS
work_4qabwxy7effildblswnw7mkrvi	31	61	require	require	VBP
work_4qabwxy7effildblswnw7mkrvi	31	62	more	more	JJR
work_4qabwxy7effildblswnw7mkrvi	31	63	medications	medication	NNS
work_4qabwxy7effildblswnw7mkrvi	31	64	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	31	65	control	control	VB
work_4qabwxy7effildblswnw7mkrvi	31	66	chronic	chronic	JJ
work_4qabwxy7effildblswnw7mkrvi	31	67	illnesses	illness	NNS
work_4qabwxy7effildblswnw7mkrvi	31	68	,	,	,
work_4qabwxy7effildblswnw7mkrvi	31	69	says	say	VBZ
work_4qabwxy7effildblswnw7mkrvi	31	70	Fendrick	Fendrick	NNP
work_4qabwxy7effildblswnw7mkrvi	31	71	.	.	.
work_4qabwxy7effildblswnw7mkrvi	32	1	“	"	``
work_4qabwxy7effildblswnw7mkrvi	32	2	As	as	IN
work_4qabwxy7effildblswnw7mkrvi	32	3	we	-PRON-	PRP
work_4qabwxy7effildblswnw7mkrvi	32	4	realize	realize	VBP
work_4qabwxy7effildblswnw7mkrvi	32	5	that	that	IN
work_4qabwxy7effildblswnw7mkrvi	32	6	many	many	JJ
work_4qabwxy7effildblswnw7mkrvi	32	7	chronic	chronic	JJ
work_4qabwxy7effildblswnw7mkrvi	32	8	dis-	dis-	IN
work_4qabwxy7effildblswnw7mkrvi	32	9	eases	ease	NNS
work_4qabwxy7effildblswnw7mkrvi	32	10	will	will	MD
work_4qabwxy7effildblswnw7mkrvi	32	11	require	require	VB
work_4qabwxy7effildblswnw7mkrvi	32	12	more	more	JJR
work_4qabwxy7effildblswnw7mkrvi	32	13	than	than	IN
work_4qabwxy7effildblswnw7mkrvi	32	14	one	one	CD
work_4qabwxy7effildblswnw7mkrvi	32	15	agent	agent	NN
work_4qabwxy7effildblswnw7mkrvi	32	16	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	32	17	appropriately	appropriately	RB
work_4qabwxy7effildblswnw7mkrvi	32	18	manage	manage	VB
work_4qabwxy7effildblswnw7mkrvi	32	19	conditions	condition	NNS
work_4qabwxy7effildblswnw7mkrvi	32	20	such	such	JJ
work_4qabwxy7effildblswnw7mkrvi	32	21	as	as	IN
work_4qabwxy7effildblswnw7mkrvi	32	22	hypertension	hypertension	NN
work_4qabwxy7effildblswnw7mkrvi	32	23	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	32	24	diabetes	diabetes	NN
work_4qabwxy7effildblswnw7mkrvi	32	25	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	32	26	asthma	asthma	NN
work_4qabwxy7effildblswnw7mkrvi	32	27	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	32	28	emphysema	emphysema	NNP
work_4qabwxy7effildblswnw7mkrvi	32	29	,	,	,
work_4qabwxy7effildblswnw7mkrvi	32	30	it	-PRON-	PRP
work_4qabwxy7effildblswnw7mkrvi	32	31	would	would	MD
work_4qabwxy7effildblswnw7mkrvi	32	32	n’t	not	RB
work_4qabwxy7effildblswnw7mkrvi	32	33	surprise	surprise	VB
work_4qabwxy7effildblswnw7mkrvi	32	34	me	-PRON-	PRP
work_4qabwxy7effildblswnw7mkrvi	32	35	at	at	RB
work_4qabwxy7effildblswnw7mkrvi	32	36	all	all	RB
work_4qabwxy7effildblswnw7mkrvi	32	37	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	32	38	see	see	VB
work_4qabwxy7effildblswnw7mkrvi	32	39	additional	additional	JJ
work_4qabwxy7effildblswnw7mkrvi	32	40	and	and	CC
work_4qabwxy7effildblswnw7mkrvi	32	41	perhaps	perhaps	RB
work_4qabwxy7effildblswnw7mkrvi	32	42	more	more	RBR
work_4qabwxy7effildblswnw7mkrvi	32	43	sophisticated	sophisticated	JJ
work_4qabwxy7effildblswnw7mkrvi	32	44	combination	combination	NN
work_4qabwxy7effildblswnw7mkrvi	32	45	therapies	therapy	NNS
work_4qabwxy7effildblswnw7mkrvi	32	46	to	to	TO
work_4qabwxy7effildblswnw7mkrvi	32	47	help	help	VB
work_4qabwxy7effildblswnw7mkrvi	32	48	patients	patient	NNS
work_4qabwxy7effildblswnw7mkrvi	32	49	comply	comply	VB
work_4qabwxy7effildblswnw7mkrvi	32	50	with	with	IN
work_4qabwxy7effildblswnw7mkrvi	32	51	increasingly	increasingly	RB
work_4qabwxy7effildblswnw7mkrvi	32	52	complex	complex	JJ
work_4qabwxy7effildblswnw7mkrvi	32	53	drug	drug	NN
work_4qabwxy7effildblswnw7mkrvi	32	54	regimens	regimen	VBZ
work_4qabwxy7effildblswnw7mkrvi	32	55	.	.	.
work_4qabwxy7effildblswnw7mkrvi	32	56	”	"	''
work_4qabwxy7effildblswnw7mkrvi	32	57	—	—	:
work_4qabwxy7effildblswnw7mkrvi	32	58	Roger	Roger	NNP
work_4qabwxy7effildblswnw7mkrvi	32	59	Collier	Collier	NNP
work_4qabwxy7effildblswnw7mkrvi	32	60	,	,	,
work_4qabwxy7effildblswnw7mkrvi	32	61	CMAJ	CMAJ	NNP
work_4qabwxy7effildblswnw7mkrvi	32	62	CMAJ	CMAJ	NNP
work_4qabwxy7effildblswnw7mkrvi	32	63	2011	2011	CD
work_4qabwxy7effildblswnw7mkrvi	32	64	.	.	.
work_4qabwxy7effildblswnw7mkrvi	33	1	DOI:10.1503	DOI:10.1503	NNP
work_4qabwxy7effildblswnw7mkrvi	33	2	/	/	SYM
work_4qabwxy7effildblswnw7mkrvi	33	3	cmaj.109	cmaj.109	NNP
work_4qabwxy7effildblswnw7mkrvi	33	4	-	-	HYPH
work_4qabwxy7effildblswnw7mkrvi	33	5	4076	4076	CD
work_4qabwxy7effildblswnw7mkrvi	33	6	E118	E118	NNP
work_4qabwxy7effildblswnw7mkrvi	33	7	CMAJ	CMAJ	NNP
work_4qabwxy7effildblswnw7mkrvi	33	8	,	,	,
work_4qabwxy7effildblswnw7mkrvi	33	9	February	February	NNP
work_4qabwxy7effildblswnw7mkrvi	33	10	7	7	CD
work_4qabwxy7effildblswnw7mkrvi	33	11	,	,	,
work_4qabwxy7effildblswnw7mkrvi	33	12	2012	2012	CD
work_4qabwxy7effildblswnw7mkrvi	33	13	,	,	,
work_4qabwxy7effildblswnw7mkrvi	33	14	184(2	184(2	CD
work_4qabwxy7effildblswnw7mkrvi	33	15	)	)	-RRB-